SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-022918
Filing Date
2022-11-08
Accepted
2022-11-08 08:01:17
Documents
85
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q fusn-20220930.htm   iXBRL 10-Q 3387381
2 EX-10.1 fusn-ex10_1.htm EX-10.1 92457
3 EX-10.2 fusn-ex10_2.htm EX-10.2 529186
4 EX-31.1 fusn-ex31_1.htm EX-31.1 20907
5 EX-31.2 fusn-ex31_2.htm EX-31.2 20904
6 EX-32.1 fusn-ex32_1.htm EX-32.1 11583
7 EX-32.2 fusn-ex32_2.htm EX-32.2 12442
  Complete submission text file 0000950170-22-022918.txt   13535134

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT fusn-20220930_lab.xml EX-101.LAB 565934
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT fusn-20220930_pre.xml EX-101.PRE 395845
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT fusn-20220930.xsd EX-101.SCH 71858
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT fusn-20220930_cal.xml EX-101.CAL 62068
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT fusn-20220930_def.xml EX-101.DEF 193937
79 EXTRACTED XBRL INSTANCE DOCUMENT fusn-20220930_htm.xml XML 2911542
Mailing Address 270 LONGWOOD ROAD SOUTH HAMILTON A6 L8P 0A6
Business Address 270 LONGWOOD ROAD SOUTH HAMILTON A6 L8P 0A6 289-799-0891
Fusion Pharmaceuticals Inc. (Filer) CIK: 0001805890 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39344 | Film No.: 221367318
SIC: 2836 Biological Products, (No Diagnostic Substances)